PT100914A - Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv - Google Patents
Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hivInfo
- Publication number
- PT100914A PT100914A PT100914A PT10091492A PT100914A PT 100914 A PT100914 A PT 100914A PT 100914 A PT100914 A PT 100914A PT 10091492 A PT10091492 A PT 10091492A PT 100914 A PT100914 A PT 100914A
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- exchange
- mixed
- compounds
- ligacation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76780291A | 1991-09-30 | 1991-09-30 | |
US86521992A | 1992-04-08 | 1992-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT100914A true PT100914A (pt) | 1993-10-29 |
Family
ID=27117960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT100914A PT100914A (pt) | 1991-09-30 | 1992-09-29 | Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0607252B1 (pt) |
JP (1) | JPH06511008A (pt) |
AT (1) | ATE173625T1 (pt) |
AU (1) | AU675412B2 (pt) |
BR (1) | BR9206571A (pt) |
CA (1) | CA2120140A1 (pt) |
DE (1) | DE69227696T2 (pt) |
MX (1) | MX9205549A (pt) |
OA (1) | OA09917A (pt) |
PT (1) | PT100914A (pt) |
WO (1) | WO1993006832A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9303854D0 (en) * | 1993-02-25 | 1993-04-14 | Holt John A G | Method for enhancing t-cell count |
US5725870A (en) * | 1993-10-15 | 1998-03-10 | Thoene; Jess G. | Methods, composites and articles for contraception |
CA2173964A1 (en) * | 1993-10-15 | 1995-04-20 | Jess G. Thoene | Prevention of hiv infection |
US5886000A (en) * | 1994-01-26 | 1999-03-23 | Nissui Pharmaceutical Co., Ltd, | Anti-HIV agent |
US5734081A (en) * | 1994-08-05 | 1998-03-31 | Warner-Lambert Company | Arylthio compounds |
US5463122A (en) * | 1994-08-05 | 1995-10-31 | Warner-Lambert Company | Arylthio compounds |
US5846958A (en) * | 1995-02-17 | 1998-12-08 | U.S. Bioscience, Inc. | Methods of using aminothiols to promote hematopoietic progenitor cell growth |
EP0868900A1 (de) * | 1997-03-14 | 1998-10-07 | Wella Aktiengesellschaft | Mittel und Verfahren zur daurerhaften Haarverformung |
JP3012923B2 (ja) | 1998-01-26 | 2000-02-28 | 新潟大学長 | Cagリピート病の治療薬 |
US6600076B1 (en) * | 1999-04-05 | 2003-07-29 | The Regents Of The University Of California | Cleavable, water-soluble surfactants |
WO2004024129A1 (en) * | 2002-09-10 | 2004-03-25 | Samir Chachoua | Induced remission therapy |
AR057623A1 (es) | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
WO2010138419A2 (en) * | 2009-05-23 | 2010-12-02 | Obio Pharmaceutical (H.K.) Ltd. | Materials and methods for treating viral infections |
WO2011046901A2 (en) * | 2009-10-12 | 2011-04-21 | Walker Dale M | Broad spectrum antiviral and methods of use |
ES2770113T3 (es) | 2015-07-02 | 2020-06-30 | Horizon Orphan Llc | Análogos de la cisteamina resistentes a la ADO y sus usos |
CN117599029A (zh) | 2016-03-17 | 2024-02-27 | 硫创治疗公司 | 用于控制释放半胱胺和系统治疗半胱胺敏感性病症的组合物 |
WO2019060634A1 (en) | 2017-09-20 | 2019-03-28 | Thiogenesis Therapeutics, Inc. | METHODS OF TREATING CYSTEAMINE SENSITIVE DISORDERS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1055560B (it) * | 1974-05-02 | 1982-01-11 | Istituto Chemioterapico | Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali |
DE3684514D1 (de) * | 1985-06-08 | 1992-04-30 | Asta Medica Ag | Verwendung von penicillamin zur behandlung von immunmangelkrankheiten. |
CA1339070C (en) * | 1989-01-26 | 1997-07-29 | Wulf Droge | Treatment of diseases associated with cysteine deficiency |
WO1990014007A1 (en) * | 1989-05-24 | 1990-11-29 | U.S. Bioscience | Method for protection from azt side effects and toxicity |
EP0656787A1 (en) * | 1992-08-19 | 1995-06-14 | Trustees Of Boston University | Method of inhibiting reduction of disulfide bonds |
-
1992
- 1992-09-29 PT PT100914A patent/PT100914A/pt not_active Application Discontinuation
- 1992-09-29 MX MX9205549A patent/MX9205549A/es unknown
- 1992-09-30 JP JP5506962A patent/JPH06511008A/ja active Pending
- 1992-09-30 AU AU27557/92A patent/AU675412B2/en not_active Ceased
- 1992-09-30 BR BR9206571A patent/BR9206571A/pt not_active Application Discontinuation
- 1992-09-30 AT AT92921278T patent/ATE173625T1/de not_active IP Right Cessation
- 1992-09-30 WO PCT/US1992/008156 patent/WO1993006832A1/en active IP Right Grant
- 1992-09-30 DE DE69227696T patent/DE69227696T2/de not_active Expired - Fee Related
- 1992-09-30 CA CA002120140A patent/CA2120140A1/en not_active Abandoned
- 1992-09-30 EP EP92921278A patent/EP0607252B1/en not_active Expired - Lifetime
-
1994
- 1994-03-28 OA OA60486A patent/OA09917A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR9206571A (pt) | 1995-10-17 |
EP0607252B1 (en) | 1998-11-25 |
DE69227696D1 (de) | 1999-01-07 |
DE69227696T2 (de) | 1999-05-20 |
AU2755792A (en) | 1993-05-03 |
WO1993006832A1 (en) | 1993-04-15 |
EP0607252A4 (en) | 1996-03-13 |
JPH06511008A (ja) | 1994-12-08 |
EP0607252A1 (en) | 1994-07-27 |
CA2120140A1 (en) | 1993-04-15 |
MX9205549A (es) | 1993-05-01 |
AU675412B2 (en) | 1997-02-06 |
OA09917A (en) | 1994-09-15 |
ATE173625T1 (de) | 1998-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT100914A (pt) | Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv | |
ES2056963T3 (es) | Agentes antibacterianos. | |
RU93045710A (ru) | Противовирусная нуклеозидная композиция, способ ее получения и способ лечения | |
ATE100098T1 (de) | Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen. | |
ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
DK52487D0 (da) | Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser | |
MX9203629A (es) | Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b. | |
ATE70715T1 (de) | Bindungsinduzierende komposition. | |
ES2079068T3 (es) | 2-amino-6-fenil-4h-piran-4-onas antiateroscleroticas y antitromboticas. | |
SE8700203L (sv) | Pyroglutamidderivat | |
DK462687A (da) | Forbindelse til behandling af retrovirusinfektioner. | |
ATE71840T1 (de) | Virushemmende nukleosidmischung. | |
TR26931A (tr) | Lak koagülasyonunda molipten bilesiklerinin kullanilmasi. | |
ES2060606T3 (es) | Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones. | |
IT1265647B1 (it) | Composizione farmaceutiche topiche per le allergie respiratorie | |
BR9106596A (pt) | Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto | |
PT89582B (pt) | Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos | |
ES2055700T3 (es) | Mezclas bactericidas. | |
IT1212137B (it) | Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali. | |
RU94020393A (ru) | Способ лечения вич-инфекций | |
FR2697532B1 (fr) | Utilisation de compositions silicones pour le traitement de joints plats, notamment de joints de culasse. | |
FI862995A (fi) | Fenyl-(4-hexametyleniminopropyl) -keton. | |
ES2058784T3 (es) | Composiciones quimicas. | |
IT1233376B (it) | Composizione farmaceutica contenente n-acetil-cisteina e suo impiego |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19930521 |
|
FC3A | Refusal |
Effective date: 19990427 |